New Arthritis Medication

Featured Health Expert
38_8584
EXPERT

Patent Granted for New Rheumatoid Arthritis Medication Product R

ADVR, a bio-pharmaceutical company, recently announced that effective June 27, 2006, the company received US patent approval for treatment of rheumatoid arthritis by administering Product R (AVR118). Product R is a peptide-nucleic acid preparation. It’s combinations of peptides, amino acids, nucleosides, nucleotides and nucleic acid bases modulate the immune system.

According to the company’s website, the drug “appears to stimulate the pro inflammatory response required to combat...
Read more

More information on "New Arthritis Medication"

From Our Experts

See more SharePosts »

From Our Sources

More on Osteoarthritis »